297
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Laboratory and Imaging Evaluation of Cardiac Involvement in Patients with Post-Acute COVID-19

ORCID Icon, ORCID Icon, , , , , , , & show all
Pages 4977-4985 | Published online: 29 Aug 2021

References

  • Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061–1069. doi:10.1001/jama.2020.1585
  • Hendren NS, Drazner MH, Bozkurt B, Cooper LT Jr. Description and proposed management of the acute COVID-19 cardiovascular syndrome. Circulation. 2020;141:1903–1914. doi:10.1161/CIRCULATIONAHA.120.047349
  • Perrin R, Riste L, Hann M, Walther A, Mukherjee A, Heald A. Into the looking glass: post-viral syndrome post COVID-19. Med Hypotheses. 2020;144:110055. doi:10.1016/j.mehy.2020.110055
  • Peretto G, Sala S, Rizzo S, et al. Ventricular arrhythmias in myocarditis: characterization and relationships with myocardial inflammation. J Am Coll Cardiol. 2020;75:1046–1057. doi:10.1016/j.jacc.2020.01.036
  • Bowles KH, McDonald M, Barrón Y, Kennedy E, O’Connor M, Mikkelsen M. Surviving COVID-19 after hospital discharge: symptom, functional, and adverse outcomes of home health recipients. Ann Intern Med. 2021;174:316–325. doi:10.7326/M20-5206
  • Onodera M, Nakamura M, Tanaka F, et al. Plasma B-type natriuretic peptide is useful for cardiovascular risk assessment in community-based diabetes subjects: comparison with albuminuria. Int Heart J. 2012;53:176–181. doi:10.1536/ihj.53.176
  • Welsh P, Hart C, Papacosta O, et al. Prediction of cardiovascular disease risk by cardiac biomarkers in 2 United Kingdom cohort studies: does utility depend on risk thresholds for treatment? Hypertension. 2016;67:309–315. doi:10.1161/HYPERTENSIONAHA.115.06501
  • Gao L, Jiang D, Wen XS, et al. Prognostic value of NT-proBNP in patients with severe COVID-19. Respir Res. 2020;21:83. doi:10.1186/s12931-020-01352-w
  • Fang W, Jiang J, Su L, et al. The role of NO in COVID-19 and potential therapeutic strategies. Free Radic Biol Med. 2021;163:153–162. doi:10.1016/j.freeradbiomed.2020.12.008
  • Bailey DL, Antoch G, Bartenstein P, et al. Combined PET/MR: the real work has just started. Summary report of the Third International Workshop on PET/MR Imaging; February 17–21, 2014, Tübingen, Germany. Mol Imaging Biol. 2015;17:297–312. doi:10.1007/s11307-014-0818-0
  • Hendel RC, Berman DS, Di Carli MF, et al. ACCF/ASNC/ ACR/AHA/ASE/SCCT/SCMR/SNM Appropriate Use Criteria for Cardiac Radionuclide Imaging: a Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. J Am Coll Cardiol. 2009;53:2201–2229.
  • Kilic Y, Ozer A, Tatar T, et al. Effect of picroside II on hind limb ischemia reperfusion injury in rats. Drug Des Devel Ther. 2017;11:1917–1925. doi:10.2147/DDDT.S132401
  • Kucuk A, Polat Y, Kilicarslan A, et al. Irisin protects against hind limb ischemia reperfusion injury. Drug Des Devel Ther. 2021;15:361–368. doi:10.2147/DDDT.S279318
  • Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1–39.e14. doi:10.1016/j.echo.2014.10.003
  • Saricam E, Saglam Y, Hazirolan T. Clinical evaluation of myocardial involvement in acute myopericarditis in young adults. BMC Cardiovasc Disord. 2017;17:129. doi:10.1186/s12872-017-0564-8
  • Kochi AN, Tagliari AP, Forleo GB, Fassini GM, Tondo C. Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovasc Electrophysiol. 2020;31:1003–1008. doi:10.1111/jce.14479
  • Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020;5:831–840. doi:10.1001/jamacardio.2020.1286
  • Del Ry S, Cabiati M, Clerico A. Natriuretic peptide system and the heart. Front Horm Res. 2014;43:134–143.
  • Volpe M, Rubattu S, Burnett J. Natriuretic peptides in cardiovascular diseases: current use and perspectives. Eur Heart J. 2014;35:419–425. doi:10.1093/eurheartj/eht466
  • Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18:891–975.
  • Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62:e147–e239. doi:10.1016/j.jacc.2013.05.019
  • Cyr RA, Huckaby LV, Shiva SS, Zuckerbraun BS. Nitric oxide and endothelial dysfunction. Crit Care Clin. 2020;36:307–321. doi:10.1016/j.ccc.2019.12.009
  • Banerjee P. Heart failure: a story of damage, fatigue and injury? Open Heart. 2017;4:e000684. doi:10.1136/openhrt-2017-000684
  • Giamouzis G, Schelbert EB, Butler J. Growing evidence linking microvascular dysfunction with heart failure with preserved ejection fraction. J Am Heart Assoc. 2016;5:e003259. doi:10.1161/JAHA.116.003259
  • Duerr GD, Heine A, Hamiko M, et al. Parameters predicting COVID-19-induced myocardial injury and mortality. Life Sci. 2020;260:118400. doi:10.1016/j.lfs.2020.118400
  • Lindner D, Fitzek A, Bräuninger H, et al. Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA Cardiol. 2020;5(11):1281–1285. doi:10.1001/jamacardio.2020.3551
  • Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol. 2009;53:1475–1487. doi:10.1016/j.jacc.2009.02.007
  • Ferreira VM, Schulz-Menger J, Holmvang G, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol. 2018;72:3158–3176. doi:10.1016/j.jacc.2018.09.072
  • Luetkens JA, Isaak A, Oztürk C, et al. Cardiac MRI in Suspected Acute COVID-19 Myocarditis. Radiol Cardiothorac Imaging. 2021;3(2):e200628. doi:10.1148/ryct.2021200628
  • Luetkens JA, Isaak A, Zimmer S, et al. Diffuse myocardial inflammation in COVID-19 associated myocarditis detected by multiparametric cardiac magnetic resonance imaging. Circ Cardiovasc Imaging. 2020;13(5):e010897. doi:10.1161/CIRCIMAGING.120.010897
  • Mishra AK, Lal A, Sahu KK, Kranis M, Sargent J. Quantifying and reporting cardiac findings in imaging of COVID-19 patients. Monaldi Arch Chest Dis. 2020;90(4). doi:10.4081/monaldi.2020.1394
  • de Roos A. Diagnosis of myocarditis at cardiac MRI: the continuing quest for improved tissue characterization. Reviews and commentary. Radiology. 2019;292:618–619. doi:10.1148/radiol.2019191476